share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Echevarria Joseph

SEC announcement ·  Apr 27 01:24
Summary by Futu AI
Joseph Echevarria, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer has not been specified, and there is no information provided on the number of shares held after the action.
Joseph Echevarria, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer has not been specified, and there is no information provided on the number of shares held after the action.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.